BUTYCORE Trademark

Trademark Overview


On Friday, February 18, 2022, a trademark application was filed for BUTYCORE with the United States Patent and Trademark Office. The USPTO has given the BUTYCORE trademark a serial number of 79340272. The federal status of this trademark filing is REGISTERED as of Tuesday, May 30, 2023. This trademark is owned by MAAT PHARMA. The BUTYCORE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biological indicators for measuring the inflammatory potential of a bacterial composition for medical purposes; bacteriological preparations for pharmaceutical use; bacteriological preparations for medical use; bacteriological culture mediums for medical use; culture media for bacteriology; pharmaceutical and veterinary products, namely, preparations for the treatment of gut dysbiosis related diseases; microbiotherapy preparations for medical use for intestinal microbiome repair

Biological analyses; preparation of biological samples for testing and analysis in research laboratories; evaluations and assessments in the fields of science and technology provided by engineers; biological research laboratory services; scientific research in biology, bacteriology and chemistry; scientific research in the field of microbiotherapy
butycore

General Information


Serial Number79340272
Word MarkBUTYCORE
Filing DateFriday, February 18, 2022
Status700 - REGISTERED
Status DateTuesday, May 30, 2023
Registration Number7064486
Registration DateTuesday, May 30, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements


Goods and ServicesBiological indicators for measuring the inflammatory potential of a bacterial composition for medical purposes; bacteriological preparations for pharmaceutical use; bacteriological preparations for medical use; bacteriological culture mediums for medical use; culture media for bacteriology; pharmaceutical and veterinary products, namely, preparations for the treatment of gut dysbiosis related diseases; microbiotherapy preparations for medical use for intestinal microbiome repair
Goods and ServicesBiological analyses; preparation of biological samples for testing and analysis in research laboratories; evaluations and assessments in the fields of science and technology provided by engineers; biological research laboratory services; scientific research in biology, bacteriology and chemistry; scientific research in the field of microbiotherapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 13, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 13, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMAAT PHARMA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR

Party NameMAAT PHARMA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameMAAT PHARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Tuesday, May 17, 2022APPLICATION FILING RECEIPT MAILED
Thursday, May 12, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 13, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 28, 2022ASSIGNED TO EXAMINER
Thursday, June 30, 2022NON-FINAL ACTION WRITTEN
Friday, July 1, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, July 28, 2022REFUSAL PROCESSED BY MPU
Thursday, July 28, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, August 17, 2022REFUSAL PROCESSED BY IB
Wednesday, January 18, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 22, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 22, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 15, 2023NOTIFICATION PROCESSED BY IB
Tuesday, May 30, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 30, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, August 30, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, September 2, 2023FINAL DISPOSITION PROCESSED
Saturday, September 2, 2023FINAL DISPOSITION NOTICE SENT TO IB
Saturday, June 15, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, September 25, 2023FINAL DECISION TRANSACTION PROCESSED BY IB